|
An outside of the united states (ous) customer contacted a siemens customer care center to report falsely depressed cancer antigen ca 19 9 (ca 19 9) results were obtained on a patient sample on atellica im 1600 analyzer.Quality controls (qcs) recovered out of ranges on the day prior and the day after the date of the event.The millipore qguard was changed, a new calibration and qc were performed and were within acceptable ranges.Siemens investigated the event and reviewed the customers bio-rad inteliq tumor marker qc level 3, which showed some imprecision in the pack-to-pack variability.The autocheck data for the analyzer was reviewed and was within acceptable limits but the water pressure was low within range and the wash probe vacuum was high with separation between the aspirate probes.A siemens customer service engineer (cse) was dispatched to the customer¿s site.During this visit, the cse replaced the vacuum regulator, water pressure pump, water pressure transducer, sensor, water line piping, wash probes, pinch tubes and wash ring manifold.The cse calibrated the vacuum and recalibrated ca19-9 following service and qc recovered within ranges.A 5-day precision study was conducted to confirm repeatability and within-laboratory precision on the atellica im analyzer using multiple ca19-9 reagent lots.Testing included bio-rad liquichek tumor marker control levels 1¿3 as well as three serum samples.All samples met acceptance criteria for both repeatability and within-lab precision across all reagent lots.These results confirm that the precision performance of the atellica im ca19-9 assay remains consistent with historical expectations.Siemens further evaluated the event and could not determine the potential cause of the falsely depressed ca19-9 patient results due to the replacement and servicing of multiple parts which is considered normal troubleshooting activities.The instrument is performing according to specifications.No further evaluation of this device is required.
|